vTv Therapeutics Inc. Class A Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
VTVT Company Description
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
VTVT Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view VTVT Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of VTVT by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by VTVT's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of VTVT in WallStreetBets Daily Discussion
VTVT News
Recent insights relating to VTVT
CNBC Recommendations
Recent picks made for VTVT stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in VTVT
Corporate Flights
Flights by private jets registered to VTVT
Our Analysis